NEK2 overexpression aggravates IL-22-induced keratinocyte proliferation and cytokine level increases and IMQ-induced psoriasis-like dermatitis
Authors:
- 20 June 2023
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1870 (8) , 119525
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Distinct roles of IL-22 in human psoriasis and inflammatory bowel diseaseCytokine & Growth Factor Reviews, 2010
- Baicalin, an emerging multi-therapeutic agent: pharmacodynamics, pharmacokinetics, and considerations from drug development perspectivesXenobiotica, 2010
- Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 AxisThe Journal of Immunology, 2009
- Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathwaysNature Genetics, 2009
- Type I Interferon: Potential Therapeutic Target for Psoriasis?PLOS ONE, 2008
- Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytesClinics in Dermatology, 2007
- Alternative Splicing Controls Nuclear Translocation of the Cell Cycle-regulated Nek2 KinaseJournal of Biological Chemistry, 2007
- Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosisNature, 2006
- IL‐22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasisEuropean Journal of Immunology, 2006
- Rootletin forms centriole-associated filaments and functions in centrosome cohesionJournal of Cell Biology, 2005